Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celltrion Healthcare
Incheon, South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
Celltrion Healthcare is active globally, commercializing multiple biosimilars and innovative biologics. Recent regulatory successes include FDA and EMA approvals for biosimilar monoclonal antibodies, covering inflammatory and oncologic indications. Their products are available in about 100 countries, with continuing expansion through acquisitions and partnerships[2][3][4][6].
- Therapeutic areas
- ImmunologyEndocrinologyRheumatologyInfectious DiseasesGastroenterologyDermatologyPulmonologyOncology
- Modalities
- Monoclonal antibodyBiosimilarBiologic
- Industry
- Biotech
02
Partnerships
TEVA Pharmaceuticals InternationalHospiraMundipharmaBiogaranKern PharmaNippon KayakuEgisOver 30 global partners in distribution
Beyond the preview
Go deeper on Celltrion Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celltrion Healthcare.